Biotechnology
Compare Stocks
2 / 10Stock Comparison
ASBPW vs HYFM
Revenue, margins, valuation, and 5-year total return — side by side.
Agricultural - Machinery
ASBPW vs HYFM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Biotechnology | Agricultural - Machinery |
| Market Cap | $125K | $5M |
| Revenue (TTM) | $2K | $146M |
| Net Income (TTM) | $-32M | $-65M |
| Gross Margin | 45.5% | 10.2% |
| Operating Margin | -10314.0% | -35.8% |
| Total Debt | $1M | $170M |
| Cash & Equiv. | $4K | $26M |
ASBPW vs HYFM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Feb 25 | May 26 | Return |
|---|---|---|---|
| Aspire Biopharma Ho… (ASBPW) | 100 | 25.3 | -74.7% |
| Hydrofarm Holdings … (HYFM) | 100 | 21.0 | -79.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ASBPW vs HYFM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ASBPW is the clearest fit if your priority is long-term compounding.
- -81.9% 10Y total return vs HYFM's -99.8%
- -66.2% vs HYFM's -75.4%
HYFM carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 1 yrs, beta 0.91
- Rev growth -16.0%, EPS growth -1.9%, 3Y rev CAGR -26.5%
- Lower volatility, beta 0.91, Low D/E 75.8%, current ratio 2.72x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -16.0% revenue growth vs ASBPW's -25.4% | |
| Quality / Margins | -44.5% margin vs ASBPW's -16K% | |
| Stability / Safety | Beta 0.91 vs ASBPW's 3.15 | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | -66.2% vs HYFM's -75.4% | |
| Efficiency (ROA) | -16.3% ROA vs ASBPW's -13.2% |
ASBPW vs HYFM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
ASBPW vs HYFM — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
HYFM leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
HYFM is the larger business by revenue, generating $146M annually — 75447.2x ASBPW's $1,941. HYFM is the more profitable business, keeping -44.5% of every revenue dollar as net income compared to ASBPW's -16351.8%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $1,941 | $146M |
| EBITDAEarnings before interest/tax | -$28M | -$23M |
| Net IncomeAfter-tax profit | -$32M | -$65M |
| Free Cash FlowCash after capex | -$4M | -$8M |
| Gross MarginGross profit ÷ Revenue | +45.5% | +10.2% |
| Operating MarginEBIT ÷ Revenue | -10314.0% | -35.8% |
| Net MarginNet income ÷ Revenue | -16351.8% | -44.5% |
| FCF MarginFCF ÷ Revenue | -1811.5% | -5.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | -33.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +46.0% | -22.7% |
Valuation Metrics
HYFM leads this category, winning 1 of 1 comparable metric.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $125,312 | $5M |
| Enterprise ValueMkt cap + debt − cash | $1M | $148M |
| Trailing P/EPrice ÷ TTM EPS | -0.01x | -0.07x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | — |
| Price / SalesMarket cap ÷ Revenue | — | 0.03x |
| Price / BookPrice ÷ Book value/share | — | 0.02x |
| Price / FCFMarket cap ÷ FCF | — | — |
Profitability & Efficiency
Evenly matched — ASBPW and HYFM each lead in 2 of 4 comparable metrics.
Profitability & Efficiency
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | — | -32.3% |
| ROA (TTM)Return on assets | -13.2% | -16.3% |
| ROICReturn on invested capital | — | -9.6% |
| ROCEReturn on capital employed | — | -12.1% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 3 |
| Debt / EquityFinancial leverage | — | 0.76x |
| Net DebtTotal debt minus cash | $1M | $143M |
| Cash & Equiv.Liquid assets | $3,633 | $26M |
| Total DebtShort + long-term debt | $1M | $170M |
| Interest CoverageEBIT ÷ Interest expense | -10.51x | -3.77x |
Total Returns (Dividends Reinvested)
ASBPW leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ASBPW five years ago would be worth $1,810 today (with dividends reinvested), compared to $16 for HYFM. Over the past 12 months, ASBPW leads with a -66.2% total return vs HYFM's -75.4%. The 3-year compound annual growth rate (CAGR) favors ASBPW at -43.4% vs HYFM's -56.8% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -18.3% | -35.0% |
| 1-Year ReturnPast 12 months | -66.2% | -75.4% |
| 3-Year ReturnCumulative with dividends | -81.9% | -91.9% |
| 5-Year ReturnCumulative with dividends | -81.9% | -99.8% |
| 10-Year ReturnCumulative with dividends | -81.9% | -99.8% |
| CAGR (3Y)Annualised 3-year return | -43.4% | -56.8% |
Risk & Volatility
HYFM leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
HYFM is the less volatile stock with a 0.91 beta — it tends to amplify market swings less than ASBPW's 3.15 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HYFM currently trades 21.8% from its 52-week high vs ASBPW's 16.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 3.15x | 0.91x |
| 52-Week HighHighest price in past year | $0.09 | $4.78 |
| 52-Week LowLowest price in past year | $0.01 | $0.81 |
| % of 52W HighCurrent price vs 52-week peak | +16.9% | +21.8% |
| RSI (14)Momentum oscillator 0–100 | 52.4 | 54.8 |
| Avg Volume (50D)Average daily shares traded | 23K | 41K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — |
| Price TargetConsensus 12-month target | — | — |
| # AnalystsCovering analysts | — | — |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | 1 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
HYFM leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). ASBPW leads in 1 (Total Returns). 1 tied.
ASBPW vs HYFM: Frequently Asked Questions
7 questions · data-driven answers · updated daily
01Which is the better long-term investment — ASBPW or HYFM?
Over the past 5 years, Aspire Biopharma Holdings, Inc.
(ASBPW) delivered a total return of -81. 9%, compared to -99. 8% for Hydrofarm Holdings Group, Inc. (HYFM). Over 10 years, the gap is even starker: ASBPW returned -81. 9% versus HYFM's -99. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
02Which is safer — ASBPW or HYFM?
By beta (market sensitivity over 5 years), Hydrofarm Holdings Group, Inc.
(HYFM) is the lower-risk stock at 0. 91β versus Aspire Biopharma Holdings, Inc. 's 3. 15β — meaning ASBPW is approximately 244% more volatile than HYFM relative to the S&P 500.
03Which is growing faster — ASBPW or HYFM?
On earnings-per-share growth, the picture is similar: Hydrofarm Holdings Group, Inc.
grew EPS -1. 9% year-over-year, compared to -381. 5% for Aspire Biopharma Holdings, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
04Which has better profit margins — ASBPW or HYFM?
Hydrofarm Holdings Group, Inc.
(HYFM) is the more profitable company, earning -35. 1% net margin versus -16351. 8% for Aspire Biopharma Holdings, Inc. — meaning it keeps -35. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HYFM leads at -27. 4% versus -10314. 0% for ASBPW. At the gross margin level — before operating expenses — ASBPW leads at 45. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
05Which pays a better dividend — ASBPW or HYFM?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
06Is ASBPW or HYFM better for a retirement portfolio?
For long-horizon retirement investors, Hydrofarm Holdings Group, Inc.
(HYFM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 91)). Aspire Biopharma Holdings, Inc. (ASBPW) carries a higher beta of 3. 15 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HYFM: -99. 8%, ASBPW: -81. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
07What are the main differences between ASBPW and HYFM?
These companies operate in different sectors (ASBPW (Healthcare) and HYFM (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.
Compare ASBPW vs SNDL
SNDL is one of the most direct listed alternatives to ASBPW.
Compare HYFM vs GRWG
GRWG is one of the most direct listed alternatives to HYFM.
Expand With GRWG + IIPR
GRWG and IIPR are the strongest missing peers across the current compare set.